363 related articles for article (PubMed ID: 21779273)
1. Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression.
Andrews PW; Kornstein SG; Halberstadt LJ; Gardner CO; Neale MC
Front Psychol; 2011; 2():159. PubMed ID: 21779273
[TBL] [Abstract][Full Text] [Related]
2. Other Antidepressants.
Schwasinger-Schmidt TE; Macaluso M
Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
[TBL] [Abstract][Full Text] [Related]
3. Depression: the case for a monoamine deficiency.
Delgado PL
J Clin Psychiatry; 2000; 61 Suppl 6():7-11. PubMed ID: 10775018
[TBL] [Abstract][Full Text] [Related]
4. [Domino principle--monoamines in bottom-view].
Sümegi A
Neuropsychopharmacol Hung; 2008 Jun; 10(3):131-40. PubMed ID: 18956617
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in the transcription of monoamine transporters in major depression.
Bristow GC; Eisenlohr-Moul T; Lotesto K; Sodhi MS
J Affect Disord; 2021 Dec; 295():1215-1219. PubMed ID: 34706435
[TBL] [Abstract][Full Text] [Related]
6. Activation of monoaminergic system contributes to the antidepressant- and anxiolytic-like effects of J147.
Pan X; Chen L; Xu W; Bao S; Wang J; Cui X; Gao S; Liu K; Avasthi S; Zhang M; Chen R
Behav Brain Res; 2021 Aug; 411():113374. PubMed ID: 34023306
[TBL] [Abstract][Full Text] [Related]
7. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
8. Monoamine neurocircuitry in depression and strategies for new treatments.
Hamon M; Blier P
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
[TBL] [Abstract][Full Text] [Related]
9. New approaches to developing antidepressants by enhancing monoaminergic neurotransmission.
Bymaster FP; McNamara RK; Tran PV
Expert Opin Investig Drugs; 2003 Apr; 12(4):531-43. PubMed ID: 12665410
[TBL] [Abstract][Full Text] [Related]
10. Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2004; 4(7):1-98. PubMed ID: 23074457
[TBL] [Abstract][Full Text] [Related]
11. Exploring the role of inflammation in major depressive disorder: beyond the monoamine hypothesis.
Pastis I; Santos MG; Paruchuri A
Front Behav Neurosci; 2023; 17():1282242. PubMed ID: 38299049
[TBL] [Abstract][Full Text] [Related]
12. The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans.
Heninger GR; Delgado PL; Charney DS
Pharmacopsychiatry; 1996 Jan; 29(1):2-11. PubMed ID: 8852528
[TBL] [Abstract][Full Text] [Related]
13. Prediction of early improvement of major depressive disorder to antidepressant medication in adolescents with radiomics analysis after ComBat harmonization based on multiscale structural MRI.
Ma H; Zhang D; Wang Y; Ding Y; Yang J; Li K
BMC Psychiatry; 2023 Jun; 23(1):466. PubMed ID: 37365541
[TBL] [Abstract][Full Text] [Related]
14. Modulation of Monoaminergic Systems by Antidepressants in the Frontal Cortex of Rats After Chronic Mild Stress Exposure.
Martín-Hernández D; Pereira MP; Tendilla-Beltrán H; Madrigal JLM; García-Bueno B; Leza JC; Caso JR
Mol Neurobiol; 2019 Nov; 56(11):7522-7533. PubMed ID: 31054078
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT.
Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Donkor Y; Hunt A; Pervin J; Lewis G
Health Technol Assess; 2021 Nov; 25(69):1-62. PubMed ID: 34842135
[TBL] [Abstract][Full Text] [Related]
16. Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial.
Hollon SD; DeRubeis RJ; Fawcett J; Amsterdam JD; Shelton RC; Zajecka J; Young PR; Gallop R
JAMA Psychiatry; 2014 Oct; 71(10):1157-64. PubMed ID: 25142196
[TBL] [Abstract][Full Text] [Related]
17. Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.
Van Leeuwen E; van Driel ML; Horowitz MA; Kendrick T; Donald M; De Sutter AI; Robertson L; Christiaens T
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013495. PubMed ID: 33886130
[TBL] [Abstract][Full Text] [Related]
18. Novel antidepressant drugs: Beyond monoamine targets.
Gonda X; Dome P; Neill JC; Tarazi FI
CNS Spectr; 2023 Feb; 28(1):6-15. PubMed ID: 34588093
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of atypical antipsychotics in depressive syndromes].
Quintin P; Thomas P
Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
[TBL] [Abstract][Full Text] [Related]
20. [Hepatitis C, interferon a and depression: main physiopathologic hypothesis].
Vignau J; Karila L; Costisella O; Canva V
Encephale; 2005; 31(3):349-57. PubMed ID: 16142050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
